Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9-17 years of age
Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9-17 years of age
复制标题
DOI：
10.4161/hv.28779
复制
发表时间：
2014-07-01
影响因子：
4.8
通讯作者：
Rahman, Mahbubur
中科院分区：
文献类型：
--
作者：
Berenson, Abbey B.;Laz, Tabassum H.;Rahman, Mahbubur
本研究的目的是检查9-17岁青少年人乳头瘤病毒（HPV）疫苗接种与家庭决定是否为孩子接种HPV疫苗的决策过程之间的关系。2011-2013年期间，从德克萨斯州东南部的3家生殖健康诊所招募了至少有一个9-17岁孩子的女性横断面样本（n = 1256）。自我管理调查包括关于HPV疫苗接种决策过程、HPV疫苗接种（开始和3剂系列完成）和人口统计学的问题。在至少有一个9至17岁女儿的母亲（n = 783）中，40%的人独立决定是否为女儿接种HPV疫苗，22%的人涉及丈夫/伴侣，31%的人涉及女儿。只有7%的受访者报告了其他形式的决策（丈夫/伴侣单独或女儿单独）。同样，对于至少有一个合格儿子的妇女（n = 759），39%单独决定，30%与丈夫/伴侣一起决定，24%与儿子一起决定，7%报告其他形式。在有女儿的母亲中，那些独立做出决定的人更有可能报告他们的女儿已经开始接种HPV疫苗系列（30%），而不是将丈夫/伴侣（10%）或女儿（20%）纳入决策过程或陈述其他类型的决策（18%）的妇女（P < 0.001）。女儿完成整个系列的数字分别为16%、6%、11%和11%（P = 0.012）。在有儿子的母亲中，观察到疫苗启动（分别为17%，4%，10%和0%）（P < 0.001）和完成（分别为7%，1%，4%和0%）（P = 0.003）的类似情况。在调整混杂变量后，这些相关性仍然显著。提高HPV疫苗接种率的宣传计划应包括父母和儿童，因为他们在决定儿童是否接种疫苗方面都发挥着重要作用。
The purpose of this study was to examine the relationship between human papillomavirus (HPV) vaccine uptake among adolescents aged 9-17 years and the decision-making process used by families in determining whether to vaccinate their children against HPV. A cross-sectional sample of women with at least one child aged 9-17 years (n = 1256) was recruited from 3 reproductive health clinics in Southeast Texas during 2011-2013. Self-administered survey included questions about the HPV vaccination decision-making process, HPV vaccine uptake (initiation and 3-dose series completion), and demographics. Among mothers with at least one 9 to 17-year-old daughter (n = 783), 40% independently decided whether or not to vaccinate their daughter against HPV, 22% involved their husbands/partners, and 31% their daughters. Only 7% of respondents reported other formats in the decision-making (husband/partner alone or daughter alone). Similarly, for women with at least one eligible son (n = 759), 39% decided alone, 30% with their husbands/partners, 24% with their sons, and 7% reported other formats. Among mothers with a daughter, those who made the decision independently were more likely to report that their daughters had initiated the HPV vaccine series (30%) compared with women who included their husbands/partners (10%) or daughters (20%) in the decision process or stated other types (18%) of decision making (P < 0.001). The respective figures for the completion of the entire series among daughters were 16%, 6%, 11%, and 11% (P = 0.012). Among mothers with a son, a similar scenario was observed for vaccine initiation (17%, 4%, 10%, and 0%, respectively) (P < 0.001) and completion (7%, 1%, 4%, and 0%, respectively) (P = 0.003). These associations remained significant after adjusting for confounder variables. Awareness programs to increase HPV vaccine uptake should include both parents and children, as all have an important role in deciding whether or not children will be vaccinated.